The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous (SC) formulation for the treatment of adult ...

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

I once turned back from visiting a nearby internal medicine clinic during lunchtime due to a cold. The waiting room was ...

FDA approves Johnson & Johnson's Rybrevant Faspro for EGFR lung cancer and expands TRUFILL use for chronic subdural hematoma ...

Patients who depend on antibody drugs often spend long hours in infusion centers. These medicines are vital for treating many ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

Niagen IV and injections perfectly align NAD+-boosting science with iCRYO’s mission to deliver solutions for recovery, performance, and healthy aging “Niagen IV is now offered at over 900 clinics ...

BETHLEHEM, Pa., Sept. 15, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Tromethamine Injection in ...

Because this type of injection delivers medication into the bloodstream, it allows for rapid absorption, which causes an immediate response. A medical professional can administer IV medications as an ...

Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you ...